PUBLISHER: IMARC | PRODUCT CODE: 2016042
PUBLISHER: IMARC | PRODUCT CODE: 2016042
Point of Care Molecular Diagnostics Market Report by Product and Service, Technology, Application, End User, and Region 2026-2034
The global point of care molecular diagnostics market size reached USD 4.4 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 9.0 Billion by 2034, exhibiting a growth rate (CAGR) of 8.09% during 2026-2034. North America dominates the market owing to its improved healthcare infrastructure, strong presence of key industry players, and high adoption of innovative diagnostic technologies. The increasing incidence of infectious diseases paired with rapid development in healthcare facilities is significantly driving the market growth.
Point-of-care (POC) molecular diagnostics refer to tests performed by physicians to diagnose and detect infectious diseases. It includes hematology, pregnancy, fertility, infectious diseases, urinalysis testing kits, and cardiometabolic and glucose monitoring devices. POC molecular diagnostics is widely used for identifying infectious agents, minimal residual disease, and gastrointestinal disorders, monitoring hemoglobin and fecal occult blood, and determining a patient's ability to metabolize a drug or drug class. These tests offer faster results, reduce complications associated with mistreatment, and improve infection control measures. As a result, POC molecular diagnostics finds extensive applications in hospitals, intensive care units (ICUs), research institutes, clinics, decentralized laboratories, and homecare facilities.
POINT OF CARE MOLECULAR DIAGNOSTICS MARKET TRENDS:
Rising Prevalence of Chronic and Infectious Diseases
The rising prevalence of diseases like cancer, diabetes, cardiovascular issues, and infectious outbreaks underscores the need for swift and precise diagnostic techniques. Point-of-care molecular diagnostics offer the benefit of prompt identification, allowing for timely medical action and efficient disease management. This is especially crucial for slowing disease progression, enhancing patient survival rates, and limiting the transmission of infectious diseases. In addition, the capability of point of care molecular diagnostics to track disease advancement and treatment efficacy enhances overall care management. With healthcare systems experiencing increased demand for diagnostic services from aging populations and changing health risks, point of care molecular diagnostics offer a scalable and effective solution. The ongoing necessity to tackle intricate health issues reinforces their acceptance, positioning disease prevalence as a key factor impelling the market growth.
Growing Geriatric Population
Elderly people are at greater risk for chronic illnesses, infectious diseases, and age-associated conditions, necessitating prompt and accurate diagnostics for effective treatment. As healthcare systems gear up to handle these increasing demands, the necessity for swift, precise, and readily available diagnostic tools is essential to facilitate early detection and intervention. The World Health Organization (WHO) emphasizes that by 2030, one in six people globally will be 60 years or older, and this figure is expected to reach 2.1 billion by 2050. Furthermore, the number of individuals aged 80 and over is predicted to grow three times, totaling 426 million by 2050. This demographic change is expected to exert significant strain on healthcare systems, highlighting the need for cutting-edge point-of-care molecular diagnostics to improve patient results, lessen hospital pressures, and facilitate effective, decentralized healthcare provision.
Emphasis on Decentralized Healthcare Delivery
With the growing healthcare needs, especially in rural, isolated, and resource-constrained areas, the need for diagnostic tools that can provide quick, accurate, and dependable results without relying on centralized lab facilities is becoming more vital. Point of care molecular diagnostics effectively tackle this issue by offering quick, on-site testing options that greatly minimize logistical obstacles like delays from sample transport, storage problems, and centralized processing delays. This decentralization guarantees that patients access earlier interventions and more precise treatment paths, leading to enhanced healthcare results and lower disease burdens. Additionally, as the focus on cost control and operational effectiveness grows, healthcare organizations are utilizing these technologies to improve patient management, boost workflow efficiency, and make the most of existing resources. Decentralized healthcare delivery remains a key growth factor for the point-of-care molecular diagnostics market by enhancing accessibility, speeding up turnaround times, and minimizing systemic inefficiencies.
POINT OF CARE MOLECULAR DIAGNOSTICS MARKET GROWTH DRIVERS:
Demand for Affordable and Accurate Diagnostic Solutions
As healthcare systems strive to ensure broad access to dependable testing, affordable molecular platforms are gaining significance. These solutions merge high precision with lower operational costs, enabling wider accessibility in clinics, pharmacies, and even home environments. Affordable diagnostic technologies simplify workflows and decrease turnaround times by removing intricate sample preparation and lessening the requirement for specialized training. This equilibrium between accuracy and cost-effectiveness facilitates the substitution of unreliable testing techniques, leading to enhanced patient results and superior disease management. As healthcare systems focus on value-based care, the need for cost-effective and precise diagnostics is a vital factor propelling the market growth. In 2024, 3EO Health launched its CLIA-waived point-of-care molecular diagnostics platform in the US, offering COVID-19 testing under $20 with no sample prep. The compact 3TR system enabled affordable, high-efficiency testing in clinics and homes, aiming to replace antigen tests with molecular accuracy.
Advancements in Portable Diagnostic Technologies
Small and easy-to-use devices are facilitating dependable testing beyond conventional lab environments, broadening access to essential diagnostic services in urban and rural regions. These advancements deliver quick, precise outcomes, aiding prompt clinical choices and minimizing the wait times linked to centralized testing centers. Improved portability enables healthcare professionals to perform testing in various settings, ranging from community health facilities to distant clinics, thus expanding healthcare access and enhancing disease management results. The simplicity of deployment, paired with low infrastructure needs, enables portable diagnostics to be highly versatile for extensive usage. Enhancing efficiency, scalability, and accessibility, innovations in portable molecular diagnostics bolster the market's contribution to advancing global healthcare delivery and guaranteeing fair access to vital testing. In 2024, India's Truenat, a point-of-care molecular diagnostics platform by Molbio, was recognized at the 77th World Health Assembly for its role in combating TB. The portable, battery-operated PCR device delivers rapid, high-accuracy results in under an hour and is widely deployed across India.
Integration with Digital Health and Data Analytics
The combination of point-of-care molecular diagnostics with digital health platforms and sophisticated data analytics is contributing to the market growth. Contemporary connectivity capabilities, such as cloud data storage, mobile health apps, and electronic health record (EHR) integration, enable the smooth transfer, access, and monitoring of diagnostic results throughout healthcare networks. This interoperability enhances clinical decision-making by enabling healthcare providers to obtain real-time data, monitor disease progression, and more efficiently coordinate personalized treatment plans. Additionally, analytics-driven insights support population health management by identifying disease trends, predicting potential outbreaks, and improving the allocation of healthcare resources. Furthermore, integrating diagnostic technologies with telemedicine services and remote monitoring systems allows patients in rural and underserved regions to access prompt, precise, and ongoing care. This cohesive ecosystem promotes enhanced precision and operational effectiveness, alongside increased patient involvement and adherence, supporting the adoption of point-of-care molecular diagnostics globally.
KEY MARKET SEGMENTATION:
Breakup by Product and Service:
- Assays and Kits
- Instruments and Analyzers
- Software and Services
Breakup by Technology:
- Polymerase Chain Reaction (PCR)
- Hybridization
- DNA sequencing
- Microarray
- Isothermal Nucleic Acid Amplification Technology (INAAT)
- Others
Breakup by Application:
- Infectious Diseases
- Oncology
- Hematology
- Prenatal Testing
- Endocrinology
- Others
Breakup by End User:
- Physicians' Offices
- Hospitals and ICUs
- Research Institutes
- Others
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
COMPETITIVE LANDSCAPE:
The report has also provided a comprehensive analysis of the competitive landscape in the global point of care molecular diagnostics market. Detailed profiles of all major companies have also been provided. Some of the companies covered include:
- Abbott Laboratories
- Becton, Dickinson and Company
- binx health, inc.
- Cepheid (Danaher Corporation)
- Co-Diagnostics Inc.
- F. Hoffmann-La Roche Ltd
- Meridian Bioscience
- Molbio Diagnostics Limited
- QuantuMDx Group Limited
- Thermo Fisher Scientific Inc.
- Visby Medical Inc.
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
KEY QUESTIONS ANSWERED IN THIS REPORT
1. What was the size of the global point of care molecular diagnostics market in 2025?
2. What is the expected growth rate of the global point of care molecular diagnostics market during 2026-2034?
3. What are the key factors driving the global point of care molecular diagnostics market?
4. What has been the impact of COVID-19 on the global point of care molecular diagnostics market?
5. What is the breakup of the global point of care molecular diagnostics market based on the product and service?
6. What is the breakup of the global point of care molecular diagnostics market based on the technology?
7. What is the breakup of the global point of care molecular diagnostics market based on application?
8. What are the key regions in the global point of care molecular diagnostics market?
9. Who are the key players/companies in the global point of care molecular diagnostics market?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Point of Care Molecular Diagnostics Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Product and Service
- 6.1 Assays and kits
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Instruments and Analyzers
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Software and Services
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
7 Market Breakup by Technology
- 7.1 Polymerase Chain Reaction (PCR)
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Hybridization
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 DNA sequencing
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Microarray
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
- 7.5 Isothermal Nucleic Acid Amplification Technology (INAAT)
- 7.5.1 Market Trends
- 7.5.2 Market Forecast
- 7.6 Others
- 7.6.1 Market Trends
- 7.6.2 Market Forecast
8 Market Breakup by Application
- 8.1 Infectious Diseases
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Oncology
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Hematology
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
- 8.4 Prenatal Testing
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
- 8.5 Endocrinology
- 8.5.1 Market Trends
- 8.5.2 Market Forecast
- 8.6 Others
- 8.6.1 Market Trends
- 8.6.2 Market Forecast
9 Market Breakup by End User
- 9.1 Physicians' Offices
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
- 9.2 Hospitals and ICUs
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
- 9.3 Research Institutes
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
- 9.4 Others
- 9.4.1 Market Trends
- 9.4.2 Market Forecast
10 Market Breakup by Region
- 10.1 North America
- 10.1.1 United States
- 10.1.1.1 Market Trends
- 10.1.1.2 Market Forecast
- 10.1.2 Canada
- 10.1.2.1 Market Trends
- 10.1.2.2 Market Forecast
- 10.1.1 United States
- 10.2 Asia-Pacific
- 10.2.1 China
- 10.2.1.1 Market Trends
- 10.2.1.2 Market Forecast
- 10.2.2 Japan
- 10.2.2.1 Market Trends
- 10.2.2.2 Market Forecast
- 10.2.3 India
- 10.2.3.1 Market Trends
- 10.2.3.2 Market Forecast
- 10.2.4 South Korea
- 10.2.4.1 Market Trends
- 10.2.4.2 Market Forecast
- 10.2.5 Australia
- 10.2.5.1 Market Trends
- 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
- 10.2.6.1 Market Trends
- 10.2.6.2 Market Forecast
- 10.2.7 Others
- 10.2.7.1 Market Trends
- 10.2.7.2 Market Forecast
- 10.2.1 China
- 10.3 Europe
- 10.3.1 Germany
- 10.3.1.1 Market Trends
- 10.3.1.2 Market Forecast
- 10.3.2 France
- 10.3.2.1 Market Trends
- 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
- 10.3.3.1 Market Trends
- 10.3.3.2 Market Forecast
- 10.3.4 Italy
- 10.3.4.1 Market Trends
- 10.3.4.2 Market Forecast
- 10.3.5 Spain
- 10.3.5.1 Market Trends
- 10.3.5.2 Market Forecast
- 10.3.6 Russia
- 10.3.6.1 Market Trends
- 10.3.6.2 Market Forecast
- 10.3.7 Others
- 10.3.7.1 Market Trends
- 10.3.7.2 Market Forecast
- 10.3.1 Germany
- 10.4 Latin America
- 10.4.1 Brazil
- 10.4.1.1 Market Trends
- 10.4.1.2 Market Forecast
- 10.4.2 Mexico
- 10.4.2.1 Market Trends
- 10.4.2.2 Market Forecast
- 10.4.3 Others
- 10.4.3.1 Market Trends
- 10.4.3.2 Market Forecast
- 10.4.1 Brazil
- 10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast
11 SWOT Analysis
- 11.1 Overview
- 11.2 Strengths
- 11.3 Weaknesses
- 11.4 Opportunities
- 11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
- 13.1 Overview
- 13.2 Bargaining Power of Buyers
- 13.3 Bargaining Power of Suppliers
- 13.4 Degree of Competition
- 13.5 Threat of New Entrants
- 13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
- 15.1 Market Structure
- 15.2 Key Players
- 15.3 Profiles of Key Players
- 15.3.1 Abbott Laboratories
- 15.3.1.1 Company Overview
- 15.3.1.2 Product Portfolio
- 15.3.1.3 Financials
- 15.3.1.4 SWOT Analysis
- 15.3.2 Becton, Dickinson and Company
- 15.3.2.1 Company Overview
- 15.3.2.2 Product Portfolio
- 15.3.2.3 Financials
- 15.3.2.4 SWOT Analysis
- 15.3.3 binx health, inc.
- 15.3.3.1 Company Overview
- 15.3.3.2 Product Portfolio
- 15.3.4 Cepheid (Danaher Corporation)
- 15.3.4.1 Company Overview
- 15.3.4.2 Product Portfolio
- 15.3.4.3 Financials
- 15.3.4.4 SWOT Analysis
- 15.3.5 Co-Diagnostics Inc.
- 15.3.5.1 Company Overview
- 15.3.5.2 Product Portfolio
- 15.3.5.3 Financials
- 15.3.6 F. Hoffmann-La Roche Ltd
- 15.3.6.1 Company Overview
- 15.3.6.2 Product Portfolio
- 15.3.6.3 Financials
- 15.3.7 Meridian Bioscience
- 15.3.7.1 Company Overview
- 15.3.7.2 Product Portfolio
- 15.3.7.3 Financials
- 15.3.7.4 SWOT Analysis
- 15.3.8 Molbio Diagnostics Limited
- 15.3.8.1 Company Overview
- 15.3.8.2 Product Portfolio
- 15.3.9 QuantuMDx Group Limited
- 15.3.9.1 Company Overview
- 15.3.9.2 Product Portfolio
- 15.3.9.3 Financials
- 15.3.9.4 SWOT Analysis
- 15.3.10 Thermo Fisher Scientific Inc.
- 15.3.10.1 Company Overview
- 15.3.10.2 Product Portfolio
- 15.3.10.3 Financials
- 15.3.10.4 SWOT Analysis
- 15.3.11 Visby Medical Inc.
- 15.3.11.1 Company Overview
- 15.3.11.2 Product Portfolio
- 15.3.1 Abbott Laboratories
List of Figures
- Figure 1: Global: Point of Care Molecular Diagnostics Market: Major Drivers and Challenges
- Figure 2: Global: Point of Care Molecular Diagnostics Market: Sales Value (in Billion USD), 2020-2025
- Figure 3: Global: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Billion USD), 2026-2034
- Figure 4: Global: Point of Care Molecular Diagnostics Market: Breakup by Product and Service (in %), 2025
- Figure 5: Global: Point of Care Molecular Diagnostics Market: Breakup by Technology (in %), 2025
- Figure 6: Global: Point of Care Molecular Diagnostics Market: Breakup by Application (in %), 2025
- Figure 7: Global: Point of Care Molecular Diagnostics Market: Breakup by End User (in %), 2025
- Figure 8: Global: Point of Care Molecular Diagnostics Market: Breakup by Region (in %), 2025
- Figure 9: Global: Point of Care Molecular Diagnostics (Assays and Kits) Market: Sales Value (in Million USD), 2020 & 2025
- Figure 10: Global: Point of Care Molecular Diagnostics (Assays and Kits) Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 11: Global: Point of Care Molecular Diagnostics (Instruments and Analyzers) Market: Sales Value (in Million USD), 2020 & 2025
- Figure 12: Global: Point of Care Molecular Diagnostics (Instruments and Analyzers) Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 13: Global: Point of Care Molecular Diagnostics (Software and Services) Market: Sales Value (in Million USD), 2020 & 2025
- Figure 14: Global: Point of Care Molecular Diagnostics (Software and Services) Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 15: Global: Point of Care Molecular Diagnostics (Polymerase Chain Reaction) Market: Sales Value (in Million USD), 2020 & 2025
- Figure 16: Global: Point of Care Molecular Diagnostics (Polymerase Chain Reaction) Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 17: Global: Point of Care Molecular Diagnostics (Hybridization) Market: Sales Value (in Million USD), 2020 & 2025
- Figure 18: Global: Point of Care Molecular Diagnostics (Hybridization) Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 19: Global: Point of Care Molecular Diagnostics (DNA sequencing) Market: Sales Value (in Million USD), 2020 & 2025
- Figure 20: Global: Point of Care Molecular Diagnostics (DNA sequencing) Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 21: Global: Point of Care Molecular Diagnostics (Microarray) Market: Sales Value (in Million USD), 2020 & 2025
- Figure 22: Global: Point of Care Molecular Diagnostics (Microarray) Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 23: Global: Point of Care Molecular Diagnostics (Isothermal Nucleic Acid Amplification Technology) Market: Sales Value (in Million USD), 2020 & 2025
- Figure 24: Global: Point of Care Molecular Diagnostics (Isothermal Nucleic Acid Amplification Technology) Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 25: Global: Point of Care Molecular Diagnostics (Other Technologies) Market: Sales Value (in Million USD), 2020 & 2025
- Figure 26: Global: Point of Care Molecular Diagnostics (Other Technologies) Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 27: Global: Point of Care Molecular Diagnostics (Infectious Diseases) Market: Sales Value (in Million USD), 2020 & 2025
- Figure 28: Global: Point of Care Molecular Diagnostics (Infectious Diseases) Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 29: Global: Point of Care Molecular Diagnostics (Oncology) Market: Sales Value (in Million USD), 2020 & 2025
- Figure 30: Global: Point of Care Molecular Diagnostics (Oncology) Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 31: Global: Point of Care Molecular Diagnostics (Hematology) Market: Sales Value (in Million USD), 2020 & 2025
- Figure 32: Global: Point of Care Molecular Diagnostics (Hematology) Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 33: Global: Point of Care Molecular Diagnostics (Prenatal Testing) Market: Sales Value (in Million USD), 2020 & 2025
- Figure 34: Global: Point of Care Molecular Diagnostics (Prenatal Testing) Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 35: Global: Point of Care Molecular Diagnostics (Endocrinology) Market: Sales Value (in Million USD), 2020 & 2025
- Figure 36: Global: Point of Care Molecular Diagnostics (Endocrinology) Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 37: Global: Point of Care Molecular Diagnostics (Other Applications) Market: Sales Value (in Million USD), 2020 & 2025
- Figure 38: Global: Point of Care Molecular Diagnostics (Other Applications) Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 39: Global: Point of Care Molecular Diagnostics (Physicians' Offices) Market: Sales Value (in Million USD), 2020 & 2025
- Figure 40: Global: Point of Care Molecular Diagnostics (Physicians' Offices) Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 41: Global: Point of Care Molecular Diagnostics (Hospitals and ICUs) Market: Sales Value (in Million USD), 2020 & 2025
- Figure 42: Global: Point of Care Molecular Diagnostics (Hospitals and ICUs) Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 43: Global: Point of Care Molecular Diagnostics (Research Institutes) Market: Sales Value (in Million USD), 2020 & 2025
- Figure 44: Global: Point of Care Molecular Diagnostics (Research Institutes) Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 45: Global: Point of Care Molecular Diagnostics (Other End Users) Market: Sales Value (in Million USD), 2020 & 2025
- Figure 46: Global: Point of Care Molecular Diagnostics (Other End Users) Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 47: North America: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
- Figure 48: North America: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 49: United States: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
- Figure 50: United States: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 51: Canada: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
- Figure 52: Canada: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 53: Asia-Pacific: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
- Figure 54: Asia-Pacific: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 55: China: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
- Figure 56: China: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 57: Japan: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
- Figure 58: Japan: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 59: India: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
- Figure 60: India: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 61: South Korea: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
- Figure 62: South Korea: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 63: Australia: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
- Figure 64: Australia: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 65: Indonesia: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
- Figure 66: Indonesia: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 67: Others: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
- Figure 68: Others: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 69: Europe: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
- Figure 70: Europe: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 71: Germany: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
- Figure 72: Germany: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 73: France: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
- Figure 74: France: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 75: United Kingdom: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
- Figure 76: United Kingdom: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 77: Italy: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
- Figure 78: Italy: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 79: Spain: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
- Figure 80: Spain: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 81: Russia: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
- Figure 82: Russia: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 83: Others: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
- Figure 84: Others: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 85: Latin America: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
- Figure 86: Latin America: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 87: Brazil: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
- Figure 88: Brazil: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 89: Mexico: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
- Figure 90: Mexico: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 91: Others: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
- Figure 92: Others: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 93: Middle East and Africa: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
- Figure 94: Middle East and Africa: Point of Care Molecular Diagnostics Market: Breakup by Country (in %), 2025
- Figure 95: Middle East and Africa: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
- Figure 96: Global: Point of Care Molecular Diagnostics Industry: SWOT Analysis
- Figure 97: Global: Point of Care Molecular Diagnostics Industry: Value Chain Analysis
- Figure 98: Global: Point of Care Molecular Diagnostics Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: Point of Care Molecular Diagnostics Market: Key Industry Highlights, 2025 and 2034
- Table 2: Global: Point of Care Molecular Diagnostics Market Forecast: Breakup by Product and Service (in Million USD), 2026-2034
- Table 3: Global: Point of Care Molecular Diagnostics Market Forecast: Breakup by Technology (in Million USD), 2026-2034
- Table 4: Global: Point of Care Molecular Diagnostics Market Forecast: Breakup by Application (in Million USD), 2026-2034
- Table 5: Global: Point of Care Molecular Diagnostics Market Forecast: Breakup by End User (in Million USD), 2026-2034
- Table 6: Global: Point of Care Molecular Diagnostics Market Forecast: Breakup by Region (in Million USD), 2026-2034
- Table 7: Global: Point of Care Molecular Diagnostics Market: Competitive Structure
- Table 8: Global: Point of Care Molecular Diagnostics Market: Key Players
